Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Restore Health
MADISON, Wis., July 9, 2014 /PRNewswire/ -- Restore Health, a leader in personalized medicine, today announced it has partnered with Aesynt to add automated sterile compounding equipment to its pharmacies. While Restore Health has an impressive safety record, the company is constantly reviewing best practices to ensure that it is embracing technologies that improve safety and efficiency, including the recently passed Compounding Quality Act legislation in Congress, with FDA's oversight and CGMP guidelines for aseptic compounding at Outsourcing Facilities.
"As a full-service personalized medicine provider, it is critical that Restore Health offer a complete solution to the sterile requirements of our clinical partners. Considering the gravity of even a single error, our company is proud to announce its commitment to and partnership with Aesynt. This partnership will allow for the use of advanced robotics ensuring the highest level of patient protection possible," said Matthew Wanderer, CEO for Restore Health. "Robotic technology will help to define the future of healthcare and specifically the optimal delivery of personalized medicine. For over 30 years, our company has demonstrated its commitment to investments in cutting-edge medical technologies, we're very much pleased to unveil this state-of-the-art technology as part of our offering."
Murray I. Firestone, Ph.D., President of Restore Health, said, "Restore's first priority is quality, and tantamount to this is safety. Aesynt's i.v.STATION enables a previously unachievable level of precision and reliability to ensure process and patient safety. Adding robotic capability to specialty compounding is just the right thing to do. Unique sterile medications that are not available from manufacturers are a medical necessity for many patients and Restore will now have the most efficient way to provide personalized, sterile, pharmacy preparations."
Gaspar DeViedma, Aesynt's Global Sales & Marketing Leader for IV Automation, stated, "i.v.STATION pioneered CGMP compliant sterile compounding at not-for-profit compounding centers in 2012 before the Compounding Quality Act passed. This new partnership with Restore Health represents a very important strategic step for Aesynt as it continues to lead the IV Automation market, this time with Restore Health's vision to become the first for-profit aseptic compounding facility to adopt IV Robotics' technology."
About Restore Health
Restore Health is the first trusted national brand wholly dedicated to bringing personalized specialty medicines to healthcare providers throughout the United States. Its unique full-service solution offers physicians integrated support of custom pharmacy, diagnostic laboratory, and clinical liaison staff. RestoreDirect is the company's proprietary I.T. platform, a cloud-based, HIPAA-compliant, enterprise resource planning (ERP) software suite. It was originally conceived nearly a decade ago and designed to meet the unique, business-critical requirements of a specialty compounding pharmacy operating in the personalized medicine space. Mirroring the growth of Restore Health and its creation of a trusted national brand, the RestoreDirect suite of integrated business applications has expanded to support Restore's remote sites and external trading partners through the full spectrum of secure transactions. Since 1982, Restore Health has established a reputation among physicians for providing personalized medications and guidance that truly make a difference in their patients' lives.
Aesynt Incorporated is committed to continuously advancing medication delivery, offering integrated pharmacy automation solutions that help health systems to support improved patient outcomes, build stronger businesses and manage ongoing change. For more information, visit www.aesynt.com. Follow Aesynt on Twitter at https://twitter.com/aesynt.
©2012 PR Newswire. All Rights Reserved.